×
CureVac is a global biopharmaceutical company with more than 20 years of experience in developing the mRNA technology for medical purposes.
CureVac

CureVac

Biotech company
CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA. Headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr, Steve Pascolo, Florian von der Mulbe, Günther Jung, and... Wikipedia
CEO: Alexander Zehnder (Apr 2023–)
Headquarters: Tübingen, Germany
Number of employees: < 700
Date founded: 2000

CureVac from en.wikipedia.org
CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA (mRNA). Headquartered in Tübingen, Germany, the company was ...
People also ask
The Curevac N.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock.
We built CureVac from life's building blocks Today, we're more than 1000 passionate people strong, each one committed to using the clinical potential of our proprietary mRNA technology to provide tailored solutions for those with the greatest medical needs.
CureVac (Nasdaq: CVAC) is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes.
Headquartered in Tübingen, Germany, CureVac also operates sites in the Netherlands, Belgium, Switzerland, and the U.S. Further information can be found at www.curevac.com.
Jul 3, 2024 · Since 2020, GSK and CureVac have worked together to develop mRNA vaccines for infectious diseases. Through this collaboration, GSK and CureVac ...
CureVac from x.com
Prophylactic vaccines, cancer therapies & molecular therapies: CureVac is a leader & pioneer in developing mRNA-based medicines https://t.co/8NlCE03ZY6.
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
2 days ago · The stock is gaining following a CDC report highlighting a significant increase in acute respiratory illnesses nationwide. Shares of CureVac BV.
This presentation of CureVac N.V. (the “company”) contains statements that constitute “forward-looking statements” as that term is defined in the United States ...